These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 16045858

  • 21. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.
    Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, Faulkner K, Crim CC.
    Mayo Clin Proc; 2004 Apr; 79(4):458-66. PubMed ID: 15065610
    [Abstract] [Full Text] [Related]

  • 22. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C, Wu EQ, Ray S, Colice GL.
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [Abstract] [Full Text] [Related]

  • 23. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
    Buyukkaplan US, Akkaya A, Yildiz M, Bircan A, Aksoy Dogan A, Ozturk O.
    J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
    [Abstract] [Full Text] [Related]

  • 24. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.
    Li JT, Ford LB, Chervinsky P, Weisberg SC, Kellerman DJ, Faulkner KG, Herje NE, Hamedani A, Harding SM, Shah T.
    J Allergy Clin Immunol; 1999 Jun; 103(6):1062-8. PubMed ID: 10359887
    [Abstract] [Full Text] [Related]

  • 25. Effects of high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma.
    Ninan TK, Reid IW, Carter PE, Smail PJ, Russell G.
    Thorax; 1993 Jun; 48(6):599-602. PubMed ID: 8346487
    [Abstract] [Full Text] [Related]

  • 26. Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma.
    Roux C, Kolta S, Desfougères JL, Minini P, Bidat E.
    Pediatrics; 2003 Jun; 111(6 Pt 1):e706-13. PubMed ID: 12777589
    [Abstract] [Full Text] [Related]

  • 27. Adrenal function as assessed by low-dose adrenocorticotropin hormone test before and after switching from inhaled beclomethasone dipropionate to inhaled fluticasone propionate.
    Niitsuma T, Okita M, Sakurai K, Morita S, Tsuyuguchi M, Matsumura Y, Hayashi T, Koshishi T, Oka K, Homma M.
    J Asthma; 2003 Jun; 40(5):515-22. PubMed ID: 14529101
    [Abstract] [Full Text] [Related]

  • 28. Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma.
    Bacharier LB, Raissy HH, Wilson L, McWilliams B, Strunk RC, Kelly HW.
    Pediatrics; 2004 Jun; 113(6):1693-9. PubMed ID: 15173493
    [Abstract] [Full Text] [Related]

  • 29. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW.
    J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
    [Abstract] [Full Text] [Related]

  • 30. Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trials.
    Pedersen S.
    Drug Saf; 2006 Jul; 29(7):599-612. PubMed ID: 16808552
    [Abstract] [Full Text] [Related]

  • 31. Effects of inhaled corticosteroids on bone density and metabolism.
    Woodcock A.
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 2):S456-9. PubMed ID: 9563372
    [Abstract] [Full Text] [Related]

  • 32. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
    Clark DJ, Clark RA, Lipworth BJ.
    Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708
    [Abstract] [Full Text] [Related]

  • 33. Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma.
    Allen HD, Thong IG, Clifton-Bligh P, Holmes S, Nery L, Wilson KB.
    Pediatr Pulmonol; 2000 Mar; 29(3):188-93. PubMed ID: 10686039
    [Abstract] [Full Text] [Related]

  • 34. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study.
    Agertoft L, Pedersen S.
    Eur Respir J; 1997 Jul; 10(7):1507-12. PubMed ID: 9230238
    [Abstract] [Full Text] [Related]

  • 35. [High doses of inhaled budesonide and adrenal function in children with severe asthma].
    Milinarsky T A, Fischer G S, Giadrosich R V, Lezana S V, Torres C MT.
    Rev Med Chil; 2006 Jan; 134(1):60-4. PubMed ID: 16532163
    [Abstract] [Full Text] [Related]

  • 36. Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism.
    Boulet LP, Giguère MC, Milot J, Brown J.
    J Allergy Clin Immunol; 1994 Nov; 94(5):796-803. PubMed ID: 7963147
    [Abstract] [Full Text] [Related]

  • 37. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N, Lundbäck B, Alton M, Rak S, Eivindson A, Bratten G, Kjaersgaard P.
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [Abstract] [Full Text] [Related]

  • 38. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
    Clark DJ, Grove A, Cargill RI, Lipworth BJ.
    Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
    [Abstract] [Full Text] [Related]

  • 39. Inhaled corticosteroids and bone density of children with asthma.
    Bahceciler NN, Sezgin G, Nursoy MA, Barlan IB, Basaran MM.
    J Asthma; 2002 Apr; 39(2):151-7. PubMed ID: 11990230
    [Abstract] [Full Text] [Related]

  • 40. Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects.
    Christensson C, Thorén A, Lindberg B.
    Drug Saf; 2008 Apr; 31(11):965-88. PubMed ID: 18840017
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.